DIMA Surelift Minimally Invasive Prolapse System Neopore - HSA Registration DE0508068
Access comprehensive regulatory information for DIMA Surelift Minimally Invasive Prolapse System Neopore in the Singapore medical device market through Pure Global AI's free database. This CLASS C medical device is registered under HSA registration number DE0508068 and owned by DESARROLLO E INVESTIGACION MEDICA ARAGONESA. The device was registered on May 04, 2023.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
Surelift Minimally Invasive Prolapse System is a transvaginal mesh system for the treatment of moderate to severe, and/or complex cases of vaginal prolapse of the anterior or posterior compartment. Surelift® Anchorsure is indicated for attaching suture to ligaments of the pelvic floor. This is intended for patients for whom all other available treatments have failed or have been determined unsuitable.